Autolus Therapeutics plc - Special Call Transcript
Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics EHA Data Update. As a reminder, this conference call is being recorded.
I would now like to turn the conference over to your host, Dr. Lucinda Crabtree, Vice President, Head of Investor Relations. Please go ahead.
Thank you, Michelle. Turning to Slide 2. Good morning or good afternoon, everyone, and thank you for taking part in today's call on the EHA Phase I data update. I am Lucinda Crabtree, Vice President of Investor Relations. With me today are Dr. Christian Itin, our Chairman and Chief Executive Officer; Dr. Vijay Reddy, our Chief Medical Officer; Dr. Nushmia Khokhar, our Vice President and Head of Clinical development; Brent Rice, our Chief Commercial Officer in the U.S.; and Andrew Oakley, our Chief Financial Officer.
Before we begin, I would like to remind you that during this call, we will be making forward-looking statements. All statements other than statements of historical
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
